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Abstract
Objective
The purpose of this systematic literature review is to
determine how exercise can be incorporated into the
treatment of major depressive disorder (MDD) and its
efficacy.
Methods
In this review, four databases were searched including
SportDiscus, Pubmed, Cochrane Database of Systematic
Reviews, and PsycInfo from October 1 to January 5, 2018. A
variety of key terms were used when searching. Works
chosen for review were published after the year 2000, were
peer reviewed, and included randomized control trials
(RCTs), pilot studies, systematic reviews, and meta-analyses.
Sources that were excluded included those published prior
to the year 2000, had poor study design, and included
comorbid psychiatric conditions varying from MDD.
Results
For this review, 17 resources were selected. Much of the
research presented shows evidence for the use of exercise in
the treatment of MDD. However, most of the research points
to exercise as more of a beneficial augmentation strategy for
MDD versus a first line therapy involving pharmacotherapy
with selective serotonin reuptake inhibitors (SSRIs) and
psychotherapy in disease treatment.
Conclusion
Current research on the topic of exercise as therapy for
MDD does show promise; however, more research still
needs to be done in order to place exercise as an equivalent
treatment to pharmacotherapy or psychotherapy.

Literature Review

The Hypothalamic–Pituitary–Cortisol System in Depression. Belmaker, R.H. & Agam, G.
(2008). Major Depressive Disorder. New England Journal of Medicine, 358(55-68). doi:
10.1056/NEJMra073096

Research Question & Analysis

• What role exercise may have in the treatment of MDD?
– Type, duration, and frequency of exercise most efficacious
for MDD treatment will be assessed
– Exercise will be compared to pharmacotherapy,
psychotherapy, and exercise as augmentation to
pharmacotherapy and/or psychotherapy
– It is expected that exercise therapy will have benefits over
SSRIs and psychotherapy but will not necessarily be
superior to the latter two
• Prevalence of MDD in the U.S. is 7%, lifetime prevalence is
• A systematic literature review will look at efficacy of the
16.6%
three therapies in regard to access, adherence, remission,
• MDD is a purely clinical diagnosis based on patient history
and improvement of symptoms
and symptoms

Introduction

• Hypotheses regarding the pathogenesis of depression:
– An imbalance in the hormones serotonin, tryptophan,
noradrenaline, and dopamine

Discussion

– Areas of the brain that show functional and structural
abnormalities include anterior cingulate, orbitofrontal
cortex, amygdala and basal ganglia, hippocampus,
prefrontal cortex, ventral striatum, hypothalamic
pituitary adrenal axis, and the nucleus accumbens

Statement of the Problem

• 1st line treatment for MDD involves psychotherapy or
pharmacotherapy with SSRIs
– Psychotherapy is difficult to access in rural areas with a
shortage of trained counselors and psychiatrists
– 40% of patients treated with SSRIs do no respond to
therapy
– Many patients treated with SSRIs complain of
undesirable side effects
• Exercise is a potential benign, accessible, and affordable
treatment option in mild to moderate MDD

•Decreased hippocampal volume and function in MRI with
increasing depressive episodes
•Theme one: Type of Exercise, Intensity, and Dose for
Therapeutic Benefit
– Neither aerobic or resistance training are superior to each
other
– Optimal therapeutic effect of exercise was 3 or more times per
week for at least 30 minutes
– Cochrane review of 39 studies showed that mixed aerobic
and anaerobic exercise was most beneficial in MDD treatment
and it took 13 to 36 sessions in order to see a large effect
– Effect of exercise drops off after greater than 3 hours per week
– Discontinuation of exercise causes worsening of depressive
symptoms – not curative
•Theme two: Exercise Compared to SSRIs and Psychotherapy
– Cochrane Review of 39 studies showed no significant
difference comparing exercise to pharmacological and
psychological treatment
– Physical exercise was compared to usual care and placebo
– Exercise compared to placebo showed a statistically
significant improvement of depressive symptoms in mild to
moderate MDD
•Theme three: Exercise as Adjunctive Therapy for Depression
– Partial responders to SSRIs were assigned either a high or low
dose exercise regimen; results showed significant
improvement of depressive symptoms and quality of life in
both groups
– All participants were given 50 mg of sertraline and allowed to
increase medication dose as needed; half of the participants
were started on an exercise regimen as well; participants who
were in the exercise group needed lower doses of sertraline
but both groups had similar reduction in depressive symptoms
– A study by Murri et al., randomized participants to sertraline
plus non-progressive exercise, sertraline plus progressive
exercise, and sertraline alone; showing a much higher
remission rate for those in either exercise group compared to
sertraline alone

Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waug, F. R., . . . Mead, G. E. (2013).
Exercise for depression. Cochrane Database of Systematic Reviews.
doi:10.1002/14651858.CD004366.pub6

• One pitfall to many of the studies is that they excluded patients
with MDD who were already living active life style and
exercising; also, participants had to be willing to participate in
an exercise regimen
• The study where participants got to choose their own intensity
of exercise showed benefit, which is useful to know
• One study did show that the most effective dose for treatment
in MDD is 30 minutes 3 times per week, which is not a very
high number and may make exercise a more attractive
treatment option for patients
• More adverse effects were seen in patients treated with
pharmacotherapy versus exercise therapy
• Antidepressants such as sertraline are given a warning that they
take weeks to months to take effect; therefore, starting patients
on an exercise regimen at the same time as medication
administration may result in a quicker improvement of
depression symptoms

Applicability to Clinical
Practice
• Exercise may play the best role as augmentation to
psychotherapy or SSRIs pharmacotherapy as it relieves
symptoms more rapidly than either of the two alone
• Starting patients on a mixed aerobic and resistance training
program, 3 or more times per week is shown to be the most
beneficial
• Patient empowerment is a major component to treating a
patient; using exercise as a treatment gives the patients
responsibility and control over their medical condition
• Concerns for using exercise as a therapy includes
compliance, access, and ease of therapy; no doubt that
taking a single pill daily is less time consuming than exercise
• Exercise has many other medical benefits including weight
reduction, musculoskeletal strengthening, and cardiac
conditioning
• More research needs to be done on the topic of exercise in
the treatment of MDD
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